Squarepoint’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Squarepoint’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,140	Closed	-$12K	–	3975
2022 Q4	$12K	Buy	+10,140	New	+$16.5K	﹤0.01%	3119
2022 Q3	–	Sell	-81,699	Closed	-$181K	–	3601
2022 Q2	$181K	Sell	81,699 -8,034	-9%	-$55.7K	﹤0.01%	2505
2022 Q1	$864K	Buy	+89,733	New	+$804K	﹤0.01%	1678

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Squarepoint's GRNA Position: Q1 2023 in Review

Squarepoint sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2023, closing a stake of 10,140 shares — an estimated $12K sold.

Squarepoint first reported a position in GRNA in Q1 2022 and held it in 3 quarters. The position peaked at $864K in Q1 2022. 60 funds tracked by Wall St. Rank hold GRNA as of Q1 2023.

Squarepoint reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 10,140 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2023, an estimated $12K.
Squarepoint first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 3 quarters.
Squarepoint's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $864K in Q1 2022.
60 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.